NATERA, INC. Foreign Income Tax Expense (Benefit), Continuing Operations
NATERA, INC. (NTRA) reported Foreign Income Tax Expense (Benefit), Continuing Operations of $100.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2022-02-25.
Discontinued › Expense Statement › Income Tax
us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations · last filed 2022-02-25
- NATERA, INC. foreign income tax expense (benefit), continuing operations for the quarter ending 2019-12-31 was -$1.90M, a 23850.00% decline year-over-year.
- NATERA, INC. foreign income tax expense (benefit), continuing operations for the quarter ending 2019-09-30 was $6.00K, a 91.04% decline year-over-year.
- NATERA, INC. foreign income tax expense (benefit), continuing operations for the quarter ending 2019-06-30 was $1.90M, a 2823.08% increase year-over-year.
- NATERA, INC. foreign income tax expense (benefit), continuing operations for the quarter ending 2019-03-31 was $74.00K, a 23.33% increase year-over-year.
- NATERA, INC. foreign income tax expense (benefit), continuing operations for fiscal 2019 was $100.00K, a 50.00% decline from fiscal 2018.
- NATERA, INC. foreign income tax expense (benefit), continuing operations for fiscal 2018 was $200.00K, a 33.33% decline from fiscal 2017.
- NATERA, INC. foreign income tax expense (benefit), continuing operations for fiscal 2017 was $300.00K, a 200.00% increase from fiscal 2016.
- NATERA, INC. foreign income tax expense (benefit), continuing operations for fiscal 2016 was $100.00K.
| Period end | Foreign Income Tax Expense (Benefit), Continuing Operations 3 month | Foreign Income Tax Expense (Benefit), Continuing Operations 6 month | Foreign Income Tax Expense (Benefit), Continuing Operations 6 month as first filed | Foreign Income Tax Expense (Benefit), Continuing Operations 9 month | Foreign Income Tax Expense (Benefit), Continuing Operations 12 month | Foreign Income Tax Expense (Benefit), Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|
| 2019-12-31 | -$1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$1.89M derived: sum of 2 quarters · filed 2022-02-25 | $6.00K derived: sum of 3 quarters · filed 2022-02-25 | $100.00K 10-K · filed 2022-02-25 | $1.90M 10-K · filed 2020-03-02 | |
| 2019-09-30 | $6.00K 10-Q · filed 2019-11-08 | $1.91M derived: sum of 2 quarters · filed 2019-11-08 | $2.00M 10-Q · filed 2019-11-08 | $1.99M derived: sum of 4 quarters · filed 2021-02-26 | ||
| 2019-06-30 | $1.90M 10-Q · filed 2019-08-09 | $2.00M 10-Q · filed 2019-08-09 | $1.98M derived: sum of 3 quarters · filed 2021-02-26 | $2.05M derived: sum of 4 quarters · filed 2021-02-26 | ||
| 2019-03-31 | $74.00K 10-Q · filed 2019-05-10 | $82.00K derived: sum of 2 quarters · filed 2021-02-26 | $149.00K derived: sum of 3 quarters · filed 2021-02-26 | $214.00K derived: sum of 4 quarters · filed 2021-02-26 | ||
| 2018-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $75.00K derived: sum of 2 quarters · filed 2021-02-26 | $140.00K derived: sum of 3 quarters · filed 2021-02-26 | $200.00K 10-K · filed 2021-02-26 | ||
| 2018-09-30 | $67.00K 10-Q · filed 2019-11-08 | $132.00K derived: sum of 2 quarters · filed 2019-11-08 | $192.00K 10-Q · filed 2019-11-08 | $292.00K derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | $65.00K 10-Q · filed 2019-08-09 | $100.00K 10-Q · filed 2019-08-09 | $125.00K 10-Q · filed 2018-08-09 | $225.00K derived: sum of 3 quarters · filed 2020-03-02 | $287.00K derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | $60.00K 10-Q · filed 2019-05-10 | $160.00K derived: sum of 2 quarters · filed 2020-03-02 | $222.00K derived: sum of 3 quarters · filed 2020-03-02 | $286.00K derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2017-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $162.00K derived: sum of 2 quarters · filed 2020-03-02 | $226.00K derived: sum of 3 quarters · filed 2020-03-02 | $300.00K 10-K · filed 2020-03-02 | $200.00K 10-K · filed 2018-03-15 | |
| 2017-09-30 | $62.00K 10-Q · filed 2018-11-09 | $126.00K derived: sum of 2 quarters · filed 2018-11-09 | $200.00K 10-Q · filed 2018-11-09 | $173.00K derived: sum of 4 quarters · filed 2019-03-15 | ||
| 2017-06-30 | $64.00K 10-Q · filed 2018-08-09 | $100.00K 10-Q · filed 2018-08-09 | $111.00K derived: sum of 3 quarters · filed 2019-03-15 | $211.00K derived: sum of 4 quarters · filed 2019-03-15 | ||
| 2017-03-31 | $47.00K 10-Q · filed 2018-05-10 | $47.00K derived: sum of 2 quarters · filed 2019-03-15 | $147.00K derived: sum of 3 quarters · filed 2019-03-15 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $100.00K derived: sum of 2 quarters · filed 2019-03-15 | $100.00K 10-K · filed 2019-03-15 | $142.00K 10-K · filed 2017-03-16 | ||
| 2016-09-30 | $100.00K 10-Q · filed 2017-11-09 | $100.00K 10-Q · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |